Annals On Call - Impact of Estrogens After Hysterectomy
Authors: Robert M. Centor, JoAnn E. Manson
Journal: Annals of Internal Medicine (2020)

Web Exclusives21 April 2020Annals On Call - Impact of Estrogens After HysterectomyFREERobert M. Centor, MD and JoAnn E. Manson, MD, DrPHRobert M. Centor, MDHuntsville Regional Medical Campus, University of Alabama Birmingham School of Medicine, Birmingham, Alabama (R.M.C.)Search for more papers by this author and JoAnn E. Manson, MD, DrPHBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (J.E.M.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/A19-0028 CME/MOC SectionsAboutVisual Abstract ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In this episode of Annals On Call, Dr. Centor discusses use of estrogen therapy in women who have had hysterectomy with bilateral salpingo-oophorectomy with Dr. JoAnn E. Manson. Listen now.Annals articles discussed include...Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy. A Randomized Trial: https://annals.org/aim/fullarticle/2749725/menopausal-estrogen-alone-therapy-health-outcomes-women-without-bilateral-oophorectomyAbout Annals On CallAnnals On Call focuses on a clinically influential article published in Annals of Internal Medicine. Dr. Robert Centor shares his own perspective on the material and interviews topic area experts to discuss, debate, and share diverse insights about patient care and health care delivery.For more information on Annals On Call and for more episodes, visit go.annals.org/OnCall. Comments0 CommentsSign In to Submit A Comment Author, Article, and Disclosure InformationAffiliations: Huntsville Regional Medical Campus, University of Alabama Birmingham School of Medicine, Birmingham, Alabama (R.M.C.)Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (J.E.M.)Disclosures: Dr. Centor has disclosed the following: Consultancy: DynaMed, MDCalc, Medscape, National Kidney Foundation, The Curbsiders. Employment: U.S. Department of Veterans Affairs. Dr. Manson has disclosed no conflicts of interest.Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Christina C. Wee, MD, MPH, Deputy Editor, reports employment with Beth Israel Deaconess Medical Center. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Yu-Xiao Yang, MD, MSCE, Deputy Editor, reports that he has no financial relationships or interest to disclose. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoMenopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy JoAnn E. Manson , Aaron K. Aragaki , Shari S. Bassuk , Rowan T. Chlebowski , Garnet L. Anderson , Jacques E. Rossouw , Barbara V. Howard , Cynthia A. Thomson , Marcia L. Stefanick , Andrew M. Kaunitz , Carolyn J. Crandall , Charles B. Eaton , Victor W. Henderson , Simin Liu , Juhua Luo , Thomas Rohan , Aladdin H. Shadyab , Gretchen Wells , Jean Wactawski-Wende , Ross L. Prentice , and Metrics 21 April 2020Volume 172, Issue 8Page: OC1KeywordsConflicts of interestDiagnostic techniquesDisclosureEstrogensHealth careHysterectomyKidneysOophorectomyPatientsRandomized trials ePublished: 21 April 2020 Issue Published: 21 April 2020 Copyright & PermissionsCopyright © 2020 by American College of Physicians. All Rights Reserved.Loading ...